JONATHAN SILVERSTEIN Insider Trading $BOLD Audentes Therapeutics, Inc.
Get free email notifications about insider trading for JONATHAN SILVERSTEIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JONATHAN SILVERSTEIN. JONATHAN SILVERSTEIN is Director in AVANIR PHARMACEUTICALS, INC. ($AVNR) and in GLAUKOS Corp ($GKOS) and Director in GLAUKOS Corp ($GKOS) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in AVEDRO INC ($AVDR) and Director in Roka BioScience, Inc. ($ROKA) and Director in scPharmaceuticals Inc. ($SCPH) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in resTORbio, Inc. ($TORC) and Director in Arcutis Biotherapeutics, Inc. ($ARQT).
JONATHAN SILVERSTEIN in Audentes Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JONATHAN SILVERSTEIN: Director
Holdings: 852,105 shares
Current Value: $13,488,822
Latest Transaction: Aug 25 2016
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JONATHAN SILVERSTEIN in Audentes Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TORC, ARQT, BOLD, AVNR, AVDR, GKOS, ICPT, SCPH, ROKA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 15.03 | 18,000 | 270,540 | 18,000 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 332,766 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 1,071,992 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 2,511,441 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 627,867 | 0 | 0 | |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | P | 15.00 | 33,334 | 500,010 | 4,801,638 | 4.8 M to 4.8 M (+0.70 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 332,766 | 0 | 4,768,304 | 4.4 M to 4.8 M (+7.50 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 1,071,992 | 0 | 4,435,538 | 3.4 M to 4.4 M (+31.87 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 2,511,441 | 0 | 3,363,546 | 852.1 K to 3.4 M (+294.73 %) |
| Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 627,867 | 0 | 852,105 | 224.2 K to 852.1 K (+280.00 %) |
Page: 1